CIK 0001527728 · Non-accelerated filer<br>Smaller reporting company
Lunai Bioworks Inc.
Sign in to watch- Ticker
- LNAI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452259340
- Phone
- 45 39179840
- Business address
- CENTURY CITY MEDICAL PLAZA, 2080 CENTURY CITY EAST, SUITE 906 LOS ANGELES, CA, 90067
- Former names
- RENOVARO INC., RENOVARO BIOSCIENCES INC., Enochian Biosciences Inc, DanDrit Biotech USA, Inc., Putnam Hills Corp.
- 10-K Report Annual Report
- UPLOAD Other SEC-generated Letter
- NT 10-K Other NT 10-K
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Delisting notice
- 8-K Event Other events
- 4 Returned to the company Director returned 833,333 shares (to the company)
- 10-Q/A Report 10-Q/A
- 8-K Event Restatement · Regulation FD disclosure
- 4/A Other acquisition Director acquired 2,000,000 shares (other)
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Other disposition Director disposed of 2,000,000 shares (other)
- 4 Open-market sale 10% owner sold 16,362 shares at $1.46 ($23,889)
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4 Open-market sale 10% owner sold 21,954 shares at $1.41 ($30,955)
- 4 Open-market sale 10% owner sold 94,526 shares at an average $1.51 ($142,827)
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale 10% owner sold 110,000 shares at an average $1.53 ($168,500)
Page 6 of 31 · 601 filings